Joseph H Oved

• Columbia University Health Sciences

  Associate professor/attending physician

• Sloan-kettering Inst Can Research

Sources: reporter.nih.gov

• Food and Drug Administration

  R01, Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia, R01FD008175, 2025–2028, 5 May 2026

Sources: reporter.nih.gov